M-inSight®

Order M-inSight®

M-inSight® is a Laboratory Developed Test (LDT) performed at Corgenix, CLIA -certified and CAP- accredited Clinical laboratory, located in Colorado (US). All our licence and accreditation documents are available in M-inSight Documentation Section.
ORDER THE TEST

Order M-inSight® now!

For Physicians and Clinicians

M-inSight® has been validated for clinical use, it can be also ordered for research purposes and clinical trials.
Please log in to the ORDERING PORTAL or create a new account.

While M-inSight® is not yet covered by private health insurance or Medicare/Medicaid, we will work with you to provide access to testing.
If you are interested in using M-inSight® in an ongoing or upcoming clinical trial, to gain deeper insights into Multiple Myeloma drug development or for publication purposes, please CONTACT US. 

For Patients

M-inSight® has been validated for clinical use.
If you are interested in tracking your MRD throughout your treatment journey using a simple blood draw, please ask your doctor.
While M-inSight® is not yet covered by private health insurance or Medicare/Medicaid, we will work with your doctor to provide access to testing. 
Have your doctor CONTACT US. 

For Pharma and BioTech

If you are interested in using M-inSight® in an ongoing or upcoming clinical trial to gain deeper insights into Multiple Myeloma drug development or treatment response, please CONTACT US.

Specimen requirements

Easy sampling :
Fresh or frozen serum, small volume

  • Volume: minimum of 200 µL serum
  • Baseline sample requirements for M-Protein sequencing (one-time process)
    • Serum with M-protein concentration by M-SPIKE > 0.2 g/dL
    • If not available, RNA from bone marrow aspirate can also be used.
  • Storage: frozen samples (-80 °C)
Shipment

Shipment instructions

Please CONTACT US, we will send you the documents related to Logistics and shipment instructions.

The Workflow

Sample journey and Report

Once the serum sample is sent to our laboratory, we will process the sample and prepare a personalized report that will be released in 3-5 days (1-2 weeks for the Patient Definition Assay).

LDT

M-inSight® is a
Laboratory Developed Test

The tests, called “laboratory-developed tests” or “LDTs” are used solely within one particular laboratory and are not distributed or sold to any other labs or health care facilities to perform on their own. The federal government, through the Clinical Laboratory Improvement Amendments (CLIA), highly regulates the evaluation and use of laboratory tests. CLIA states that laboratories must demonstrate how well LDTs perform using certain performance specifications.